0000919574-18-003237.txt : 20180501 0000919574-18-003237.hdr.sgml : 20180501 20180501133802 ACCESSION NUMBER: 0000919574-18-003237 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20180501 DATE AS OF CHANGE: 20180501 EFFECTIVENESS DATE: 20180501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Euclidean Fund For Cancer Research LP CENTRAL INDEX KEY: 0001729236 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-311389 FILM NUMBER: 18794624 BUSINESS ADDRESS: STREET 1: EUCLIDEAN TECHNOLOGIES GP, LLC STREET 2: 1325 AVENUE OF THE AMERICAS, 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-571-1670 MAIL ADDRESS: STREET 1: EUCLIDEAN TECHNOLOGIES GP, LLC STREET 2: 1325 AVENUE OF THE AMERICAS, 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 D 1 primary_doc.xml X0708 D LIVE 0001729236 Euclidean Fund For Cancer Research LP EUCLIDEAN TECHNOLOGIES GP, LLC 1325 AVENUE OF THE AMERICAS, 28TH FLOOR NEW YORK NY NEW YORK 10019 646-571-1670 DELAWARE None None Limited Partnership true 2018 -- Euclidean Technologies GP, LLC 1325 Avenue of the Americas 28th Floor New York NY NEW YORK 10019 Executive Officer Promoter General Partner -- Euclidean Technologies Management, LLC 1325 Avenue of the Americas 28th Floor New York NY NEW YORK 10019 Executive Officer Promoter Investment Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06c 3C 3C.1 false 2018-05-01 true true true false 0 Indefinite 3746999 Indefinite false 8 0 0 0 true The Investment Manager receives customary management fees. true Euclidean Fund For Cancer Research LP /s/ Michael Seckler Michael Seckler Managing Member 2018-05-01